A group of scientists in Japan have developed a computational DNA droplet that can recognise specific combinations of chemically synthesised microRNAs (miRNAs) which act as biomarkers of tumours.
Using these miRNAs as molecular input, the droplets can give a DNA logic computing output through physical DNA droplet phase separation.
He said: “If a DNA droplet can be developed which can integrate and process multiple inputs and outputs, we can use it in early disease detection as well as drug delivery systems.
“Our current study also acts as a steppingstone for research in developing intelligent artificial cells and molecular robots.”
Aqueous droplet formation by liquid-liquid phase separation (or coacervation) in macromolecules is a hot topic in life sciences research.
Of these various macromolecules that form droplets, DNA is interesting because it is predictable and programmable – qualities useful in nanotechnology.
In the recent study, the programmability of DNA was used to construct and regulate DNA droplets formed by coacervation of sequence designed DNAs.
Professor Takinoue, who is also the corresponding author, explained: “The applications of DNA droplets have been reported in cell-inspired microcompartments.
“Even though biological systems regulate their functions by combining biosensing with molecular logical computation, no literature is available on integration of DNA droplet with molecular computing.”
Developing this DNA droplet required a series of experiments.
First, the team designed three types of Y-shaped DNA nanostructures called Y-motifs A, B, and C with 3 sticky ends to make A, B, and C DNA droplets.
Typically, similar droplets band together automatically while to join dissimilar droplets a special ‘linker’ molecule required.
So, they used linker molecules to join the A droplet with B and C droplet; these linker molecules were called AB and AC linkers, respectively.
In their first experiment they evaluated the ‘AND’ operation in the AB droplet mixture by introducing two input DNAs.
In this operation, the presence of input is recorded as one while its absence is recorded as zero.
The phase separation of AB droplet mixture occurred only at (1,1), meaning when both input DNAs are present, suggesting successful application of AND operation.
Following this study, the scientists decided to introduce breast cancer tumour markers, miRNA-1 and miRNA-2, to AC droplet mixture as inputs for the AND operation.
The AND operation was successful implying that the computational DNA droplet identified the miRNAs.In subsequent experiments, the team demonstrated simultaneous AND as well as NOT operations in AB mixture with miRNA-3 and miRNA-4 breast cancer biomarkers.
Lastly, they created an ABC droplet mixture and introduced all the four breast cancer biomarkers to this solution.
The phase separation in ABC droplet depended on the linker cleavage resulting in a two-phase separation or a three-phase separation.
This property of ABC droplet enabled the researchers to demonstrate the ability to detect a set of known cancer biomarkers or detect markers of three diseases simultaneously.
Digital twins set to advance stroke care
Can AI help keep the human experience in social care?
mRNA discovery paves the way to safer vaccines
Eye scans provide crucial insights into kidney health
Key tips for accelerating the health security compliance journey
Nordic Consulting strengthens team in Ireland
Healthcare innovators and leaders honoured at Imprivata HealthCon user group and awards ceremony
Wearable communication system may reduce digital health divide
Molecule trains the immune system to prevent cancer
Diabetes patients urged to use fitness games with caution
- UK2 weeks ago
National first for openEHR portal and e-referrals solution
- Medtech4 days ago
eSight: “The technology has the potential to change someone’s life”
- News4 weeks ago
How could technology better support patient experience in the NHS?
- Entrepreneurship2 weeks ago
‘I was producing addicts every week’ – the doctor-turned-tech leader taking on the opioid crisis